Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The daily Top 10 COVID papers


  Influenza

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 385 articles:
HTML format



Single Articles


    January 2021
  1. SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
    The feasibility and performance of participant-collected mid-turbinate nasal swabs for detection of influenza virus, respiratory syncytial virus, and human metapneumovirus infections among pregnant women.
    J Infect Dis. 2021 Jan 18. pii: 6103926. doi: 10.1093.
    PubMed     Abstract available


  2. BUI CHT, Yeung HW, Ho JCW, Leung CYH, et al
    Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants.
    J Infect Dis. 2021 Jan 4. pii: 6062634. doi: 10.1093.
    PubMed     Abstract available


  3. LI L, Huang M, Shen J, Wang Y, et al
    Serum Levels of Soluble Platelet Endothelial Cell Adhesion Molecule 1 in COVID-19 Patients Are Associated With Disease Severity.
    J Infect Dis. 2021;223:178-179.
    PubMed    


  4. MONCUNILL G, Mayor A, Santano R, Jimenez A, et al
    SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-up.
    J Infect Dis. 2021;223:62-71.
    PubMed     Abstract available


  5. HENSS L, Scholz T, von Rhein C, Wieters I, et al
    Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:56-61.
    PubMed     Abstract available


  6. LEE WT, Girardin RC, Dupuis AP, Kulas KE, et al
    Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
    J Infect Dis. 2021;223:47-55.
    PubMed     Abstract available


  7. SUN H, Jain A, Leone MJ, Alabsi HS, et al
    CoVA: An Acuity Score for Outpatient Screening that Predicts Coronavirus Disease 2019 Prognosis.
    J Infect Dis. 2021;223:38-46.
    PubMed     Abstract available


  8. BAANG JH, Smith C, Mirabelli C, Valesano AL, et al
    Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
    J Infect Dis. 2021;223:23-27.
    PubMed     Abstract available


  9. ZHU J, Wu C, Wu L
    Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.
    J Infect Dis. 2021;223:19-22.
    PubMed     Abstract available


  10. YILMAZ A, Marklund E, Andersson M, Nilsson S, et al
    Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019.
    J Infect Dis. 2021;223:15-18.
    PubMed     Abstract available


  11. PATI A, Padhi S, Suvankar S, Panda AK, et al
    Minor Allele of Interferon-Induced Transmembrane Protein 3 Polymorphism (rs12252) Is Covered Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality: A Worldwide Epidemiological Investigation.
    J Infect Dis. 2021;223:175-178.
    PubMed    


  12. KIDDE J, Sahebkar A
    From Foe to Friend in COVID-19: Renin-Angiotensin System Inhibitors.
    J Infect Dis. 2021;223:174-175.
    PubMed    


  13. HICKS SM, Pohl K, Neeman T, McNamara HA, et al
    A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
    J Infect Dis. 2021;223:10-14.
    PubMed     Abstract available


  14. PILOTTO A, Masciocchi S, Volonghi I, Crabbio M, et al
    Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study.
    J Infect Dis. 2021;223:28-37.
    PubMed     Abstract available


    December 2020
  15. TENFORDE MW, Talbot HK, Trabue CH, Gaglani M, et al
    Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.
    J Infect Dis. 2020 Dec 30. pii: 6055595. doi: 10.1093.
    PubMed     Abstract available


  16. KUBALE J, Balmaseda A, Sanchez N, Lopez R, et al
    Pneumonia following symptomatic influenza infection among Nicaraguan children before and after introduction of the pneumococcal conjugate vaccine.
    J Infect Dis. 2020 Dec 22. pii: 6044070. doi: 10.1093.
    PubMed     Abstract available


  17. KIMBALL J, Zhu Y, Wyatt D, Trabue CH, et al
    Influenza Vaccine Failure Associated with Age and Immunosuppression.
    J Infect Dis. 2020 Dec 19. pii: 6041867. doi: 10.1093.
    PubMed     Abstract available


  18. FERDINANDS JM, Gaglani M, Ghamande S, Martin ET, et al
    Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
    J Infect Dis. 2020 Dec 18. pii: 6041424. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  19. CLEMENS EA, Holbrook BC, Kanekiyo M, Yewdell JW, et al
    An R848 conjugated influenza virus vaccine elicits robust IgG to hemagglutinin stem in a newborn nonhuman primate model.
    J Infect Dis. 2020 Nov 27. pii: 6007684. doi: 10.1093.
    PubMed     Abstract available


  20. TAN TQ, Kullar R, Swartz TH, Mathew TA, et al
    Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1951-1954.
    PubMed     Abstract available


  21. SCHWAIGER J, Karbiener M, Aberham C, Farcet MR, et al
    No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.
    J Infect Dis. 2020;222:1960-1964.
    PubMed     Abstract available


  22. VITTE J, Diallo AB, Boumaza A, Lopez A, et al
    A Granulocytic Signature Identifies COVID-19 and Its Severity.
    J Infect Dis. 2020;222:1985-1996.
    PubMed     Abstract available


  23. BENNER SE, Patel EU, Laeyendecker O, Pekosz A, et al
    SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
    J Infect Dis. 2020;222:1974-1984.
    PubMed     Abstract available


  24. NARANBHAI V, Chang CC, Beltran WFG, Miller TE, et al
    High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
    J Infect Dis. 2020;222:1955-1959.
    PubMed     Abstract available


  25. GNIFFKE EP, Harrington WE, Dambrauskas N, Jiang Y, et al
    Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay.
    J Infect Dis. 2020;222:1965-1973.
    PubMed     Abstract available


  26. SCHIEFFELIN JS
    Infectious Disease Outbreaks: The Need For an All-in Approach.
    J Infect Dis. 2020;222:1941-1942.
    PubMed    


  27. FALASCA L, Nardacci R, Colombo D, Lalle E, et al
    Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
    J Infect Dis. 2020;222:1807-1815.
    PubMed     Abstract available


  28. BINDER RA, Alarja NA, Robie ER, Kochek KE, et al
    Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients.
    J Infect Dis. 2020;222:1798-1806.
    PubMed     Abstract available


  29. STERLING RK, Oakes T, Gal TS, Stevens MP, et al
    The Fibrosis-4 Index Is Associated With Need for Mechanical Ventilation and 30-Day Mortality in Patients Admitted With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1794-1797.
    PubMed     Abstract available


  30. GUERVILLY C, Burtey S, Sabatier F, Cauchois R, et al
    Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
    J Infect Dis. 2020;222:1789-1793.
    PubMed     Abstract available


  31. ZOU Y, Wang BR, Sun L, Xu S, et al
    The Issue of Recurrently Positive Patients Who Recovered From COVID-19 According to the Current Discharge Criteria: Investigation of Patients from Multiple Medical Institutions in Wuhan, China.
    J Infect Dis. 2020;222:1784-1788.
    PubMed     Abstract available


  32. FJELLTVEIT EB, Cox RJ, Ostensjo J, Blomberg B, et al
    Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults.
    J Infect Dis. 2020 Nov 5. pii: 5957176. doi: 10.1093.
    PubMed     Abstract available


  33. MARTIN ET, Cheng C, Petrie JG, Alyanak E, et al
    Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    J Infect Dis. 2020 Nov 3. pii: 5952469. doi: 10.1093.
    PubMed     Abstract available


  34. SALMON DA, Dudley MZ, Carleton BC
    Guillain-Barre Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.
    J Infect Dis. 2020 Nov 2. pii: 5952166. doi: 10.1093.
    PubMed    


  35. PEREZ-VILAR S, Hu M, Weintraub E, Arya D, et al
    Guillain-Barre Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
    J Infect Dis. 2020 Nov 2. pii: 5952165. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  36. WANG W, Chen X, Wang Y, Lai S, et al
    Serological evidence of human infection with avian influenza A(H7N9) virus: a systematic review and meta-analysis.
    J Infect Dis. 2020 Oct 29. pii: 5943032. doi: 10.1093.
    PubMed     Abstract available


  37. HINOJOSA M, Shepard SS, Chung JR, King JP, et al
    Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
    J Infect Dis. 2020 Oct 22. pii: 5934948. doi: 10.1093.
    PubMed     Abstract available


  38. MANCINI F, Barbanti F, Scaturro M, Fontana S, et al
    Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting.
    J Infect Dis. 2020 Oct 20. pii: 5932324. doi: 10.1093.
    PubMed     Abstract available


  39. SHANNON I, White CL, Yang H, Nayak JL, et al
    Differences in influenza-specific CD4 T cell mediated immunity following acute infection versus inactivated vaccination in children.
    J Infect Dis. 2020 Oct 19. pii: 5930368. doi: 10.1093.
    PubMed     Abstract available


  40. WEISS S, Klingler J, Hioe C, Amanat F, et al
    A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1629-1634.
    PubMed     Abstract available


  41. SAUCEDA JA, Neilands TB, Lightfoot M, Saberi P, et al
    Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1607-1611.
    PubMed     Abstract available


  42. SUGANO N, Ando W, Fukushima W
    Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Linked to Music Clubs in Osaka, Japan.
    J Infect Dis. 2020;222:1635-1640.
    PubMed     Abstract available


  43. BRADFUTE SB, Hurwitz I, Yingling AV, Ye C, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1620-1628.
    PubMed     Abstract available


  44. KOO BS, Oh H, Kim G, Hwang EH, et al
    Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques.
    J Infect Dis. 2020;222:1596-1600.
    PubMed     Abstract available


  45. LURIE MN, Silva J, Yorlets RR, Tao J, et al
    Coronavirus Disease 2019 Epidemic Doubling Time in the United States Before and During Stay-at-Home Restrictions.
    J Infect Dis. 2020;222:1601-1606.
    PubMed     Abstract available


  46. LAI CKC, Chen Z, Lui G, Ling L, et al
    Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1612-1619.
    PubMed     Abstract available


  47. SHI T, Arnott A, Semogas I, Falsey AR, et al
    The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  48. LI D, Wolk DM, Cantor MN
    Comparing Clinical Characteristics of Influenza and Common Coronavirus Infections using Electronic Health Records.
    J Infect Dis. 2020 Oct 3. pii: 5917765. doi: 10.1093.
    PubMed     Abstract available


  49. RABELO-DA-PONTE FD, Silvello D, Scherer JN, Ayala AR, et al
    Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
    J Infect Dis. 2020;222:1575-1578.
    PubMed    


  50. DEN HARTOG G, Schepp RM, Kuijer M, GeurtsvanKessel C, et al
    SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
    J Infect Dis. 2020;222:1452-1461.
    PubMed     Abstract available


  51. SCHIAFFINO MT, Di Natale M, Garcia-Martinez E, Navarro J, et al
    Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease 2019 Patients.
    J Infect Dis. 2020;222:1439-1443.
    PubMed     Abstract available


  52. WANG W, Liu X, Wu S, Chen S, et al
    Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
    J Infect Dis. 2020;222:1444-1451.
    PubMed     Abstract available


    September 2020
  53. PENKERT RR, Smith AP, Hrincius ER, McCullers JA, et al
    Vitamin A deficiency dysregulates immune responses toward influenza virus and increases mortality after bacterial coinfections.
    J Infect Dis. 2020 Sep 22. pii: 5909831. doi: 10.1093.
    PubMed     Abstract available


  54. ZHAO T
    Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1413.
    PubMed    


  55. LI JZ, Yu XG
    Overcoming Challenges in Coronavirus Disease 19 Translational Research.
    J Infect Dis. 2020;222:1254-1255.
    PubMed    


  56. LIU X, Tang J, Xie R, Li W, et al
    Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study.
    J Infect Dis. 2020;222:1293-1297.
    PubMed     Abstract available


  57. BOND K, Nicholson S, Lim SM, Karapanagiotidis T, et al
    Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting.
    J Infect Dis. 2020;222:1280-1288.
    PubMed     Abstract available


  58. LEUZINGER K, Roloff T, Gosert R, Sogaard K, et al
    Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.
    J Infect Dis. 2020;222:1270-1279.
    PubMed     Abstract available


  59. MEISTER TL, Bruggemann Y, Todt D, Conzelmann C, et al
    Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1289-1292.
    PubMed     Abstract available


  60. RIJKERS G, Murk JL, Wintermans B, van Looy B, et al
    Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    J Infect Dis. 2020;222:1265-1269.
    PubMed     Abstract available


  61. LAM KW, Chow KW, Vo J, Hou W, et al
    Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
    J Infect Dis. 2020;222:1256-1264.
    PubMed     Abstract available


  62. LEI H, Xu M, Wang X, Xie Y, et al
    Non-pharmaceutical interventions used to control COVID-19 reduced seasonal influenza transmission in China.
    J Infect Dis. 2020 Sep 8. pii: 5902938. doi: 10.1093.
    PubMed     Abstract available


  63. HADLER JL
    Will SARS-CoV-2 prevention efforts affect the coming influenza season in the United States and northern hemisphere?
    J Infect Dis. 2020 Sep 7. pii: 5902575. doi: 10.1093.
    PubMed    


  64. ZIMMERMAN RK, South-Paul JE, Poland GA
    Rationing of civilian COVID-19 vaccines while supplies are limited.
    J Infect Dis. 2020 Sep 7. pii: 5902567. doi: 10.1093.
    PubMed    


  65. NALIN D
    Immunosenescence and SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 Sep 5. pii: 5901694. doi: 10.1093.
    PubMed    


  66. LI Y, Wang X, Nair H
    Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2?
    J Infect Dis. 2020;222:1090-1097.
    PubMed     Abstract available


  67. SHOOK-SA BE, Boyce RM, Aiello AE
    Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.
    J Infect Dis. 2020;222:1086-1089.
    PubMed     Abstract available


  68. HELLEBERG M, Niemann CU, Moestrup KS, Kirk O, et al
    Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
    J Infect Dis. 2020;222:1103-1107.
    PubMed     Abstract available


  69. YAMAGISHI T, Ohnishi M, Matsunaga N, Kakimoto K, et al
    Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.
    J Infect Dis. 2020;222:1098-1102.
    PubMed     Abstract available


    August 2020
  70. TAKAHASHI S, Greenhouse B, Rodriguez-Barraquer I
    Are SARS-CoV-2 seroprevalence estimates biased?
    J Infect Dis. 2020 Aug 28. pii: 5898481. doi: 10.1093.
    PubMed    


  71. SADOFF J, De Paepe E, Haazen W, Omoruyi E, et al
    Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
    J Infect Dis. 2020 Aug 26. pii: 5897745. doi: 10.1093.
    PubMed     Abstract available


  72. HASFORD J
    Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.
    J Infect Dis. 2020 Aug 26. pii: 5897422. doi: 10.1093.
    PubMed    


  73. SHI D, Wu W, Wang Q, Xu K, et al
    Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
    J Infect Dis. 2020;222:910-918.
    PubMed     Abstract available


  74. KULLAR R, Marcelin JR, Swartz TH, Piggott DA, et al
    Racial Disparity of Coronavirus Disease 2019 in African American Communities.
    J Infect Dis. 2020;222:890-893.
    PubMed     Abstract available


  75. PILCHER CD, Westreich D, Hudgens MG
    Group Testing for Severe Acute Respiratory Syndrome- Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of Incidence.
    J Infect Dis. 2020;222:903-909.
    PubMed     Abstract available


  76. TONG M, Jiang Y, Xia D, Xiong Y, et al
    Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.
    J Infect Dis. 2020;222:894-898.
    PubMed     Abstract available


  77. HALSTEAD SB, Katzelnick L
    COVID 19 Vaccines: Should we fear ADE?
    J Infect Dis. 2020 Aug 12. pii: 5891764. doi: 10.1093.
    PubMed     Abstract available


  78. PANG Y, Wang Q, Lv M, Yu M, et al
    Influenza vaccination protects against hospitalization outcomes among older patients with cardiovascular or respiratory diseases.
    J Infect Dis. 2020 Aug 11. pii: 5890841. doi: 10.1093.
    PubMed     Abstract available


  79. GILCA R, Carazo S, Amini R, Charest H, et al
    Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Quebec, Canada.
    J Infect Dis. 2020 Aug 6. pii: 5882014. doi: 10.1093.
    PubMed     Abstract available


  80. BALTRUSAITIS K, Reed C, Sewalk K, Brownstein JS, et al
    Health-care seeking behavior for respiratory illness among Flu Near You participants in the United States during the 2015-16 through 2018-19 influenza season.
    J Infect Dis. 2020 Aug 6. pii: 5881614. doi: 10.1093.
    PubMed     Abstract available


  81. KANZAWA M, Spindler H, Anglemyer A, Rutherford GW, et al
    Will Coronavirus Disease 2019 Become Seasonal?
    J Infect Dis. 2020;222:719-721.
    PubMed     Abstract available


  82. VOO TC, Clapham H, Tam CC
    Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.
    J Infect Dis. 2020;222:715-718.
    PubMed     Abstract available


  83. CHI Y, Ge Y, Wu B, Zhang W, et al
    Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    J Infect Dis. 2020;222:746-754.
    PubMed     Abstract available


  84. IBANEZ-SAMANIEGO L, Bighelli F, Uson C, Caravaca C, et al
    Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19.
    J Infect Dis. 2020;222:726-733.
    PubMed     Abstract available


  85. YANG D, Chu H, Hou Y, Chai Y, et al
    Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    J Infect Dis. 2020;222:734-745.
    PubMed     Abstract available


  86. CLEMENTI N, Ferrarese R, Criscuolo E, Diotti RA, et al
    Interferon-beta-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
    J Infect Dis. 2020;222:722-725.
    PubMed     Abstract available


  87. WONG MCS, Huang J, Teoh JYC, Wong SH, et al
    Identifying a Capability Framework That Could Mitigate the Coronavirus Disease 2019 Pandemic in a Global Health Community.
    J Infect Dis. 2020;222:880-881.
    PubMed    


  88. DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
    Corrigendum to: Hospital Readmissions After Laboratory-Confirmed Influenza Hospitalization.
    J Infect Dis. 2020 Aug 1. pii: 5879633. doi: 10.1093.
    PubMed    


    July 2020
  89. MACIAS GIL R, Marcelin JR, Zuniga-Blanco B, Marquez C, et al
    COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States.
    J Infect Dis. 2020 Jul 30. pii: 5878913. doi: 10.1093.
    PubMed     Abstract available


  90. PANDA AK, Tripathy R, Das BK
    Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
    J Infect Dis. 2020 Jul 29. pii: 5878042. doi: 10.1093.
    PubMed    


  91. LI P, Liu J, Ma Z, Bramer WM, et al
    Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context.
    J Infect Dis. 2020;222:695-696.
    PubMed    


  92. PINTO BGG, Oliveira AER, Singh Y, Jimenez L, et al
    ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19.
    J Infect Dis. 2020;222:556-563.
    PubMed     Abstract available


  93. SCHUIT M, Ratnesar-Shumate S, Yolitz J, Williams G, et al
    Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight.
    J Infect Dis. 2020;222:564-571.
    PubMed     Abstract available


  94. BAO L, Gao H, Deng W, Lv Q, et al
    Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice.
    J Infect Dis. 2020;222:551-555.
    PubMed     Abstract available


  95. TRICOCHE AD, Wagner AL, Balmaseda A, Sanchez N, et al
    Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections.
    J Infect Dis. 2020 Jul 16. pii: 5872037. doi: 10.1093.
    PubMed     Abstract available


  96. SCHLOM J, Donahue RN
    Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.
    J Infect Dis. 2020 Jul 11. pii: 5870046. doi: 10.1093.
    PubMed    


  97. DAWSON L, Earl J, Livezey J
    Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
    J Infect Dis. 2020;222:514-516.
    PubMed    


  98. ZENG QL, Ji F, Zhang JY
    Response to Malkovsky.
    J Infect Dis. 2020;222:510-511.
    PubMed    


  99. HAO S, Lian J, Lu Y, Jia H, et al
    Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study.
    J Infect Dis. 2020;222:367-371.
    PubMed     Abstract available


  100. TRAUGOTT M, Aberle SW, Aberle JH, Griebler H, et al
    Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests.
    J Infect Dis. 2020;222:362-366.
    PubMed     Abstract available


  101. LARGENT EA, Lynch HF
    Paying Participants in COVID-19 Trials.
    J Infect Dis. 2020;222:356-361.
    PubMed     Abstract available


  102. MALKOVSKY M
    Therapeutic Plasma Exchange-Neutralizing Antibody Combination Therapy for Severe Coronavirus Disease 2019.
    J Infect Dis. 2020;222:509-510.
    PubMed    


  103. DAVERIO M, Amigoni A, Cavicchiolo ME
    Testing for Novel Coronavirus Antibodies: A Necessary Adjunct.
    J Infect Dis. 2020;222:517-518.
    PubMed    


    June 2020
  104. O'NEIL B, Ison MG, Hallouin-Bernard MC, Nilsson AC, et al
    A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study.
    J Infect Dis. 2020 Jun 30. pii: 5865447. doi: 10.1093.
    PubMed     Abstract available


  105. LI L, Li X, Guo Z, Wang Z, et al
    Influence of Storage Conditions on SARS-CoV-2 Nucleic Acid Detection in Throat Swabs.
    J Infect Dis. 2020;222:203-205.
    PubMed     Abstract available


  106. RATNESAR-SHUMATE S, Williams G, Green B, Krause M, et al
    Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces.
    J Infect Dis. 2020;222:214-222.
    PubMed     Abstract available


  107. BURBELO PD, Riedo FX, Morishima C, Rawlings S, et al
    Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:206-213.
    PubMed     Abstract available


  108. KOBAYASHI KI, Kaki T, Mizuno S, Kubo K, et al
    Clinical Characteristics of Patients With Coronavirus Disease 2019 in Japan: A Single-Center Case Series.
    J Infect Dis. 2020;222:194-197.
    PubMed     Abstract available


  109. CAI XF, Chen J, Li Hu J, Long QX, et al
    A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:189-193.
    PubMed     Abstract available


  110. JIANG M, Guo Y, Luo Q, Huang Z, et al
    T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:198-202.
    PubMed     Abstract available


  111. ZHANG G, Nie S, Zhang Z, Zhang Z, et al
    Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
    J Infect Dis. 2020;222:183-188.
    PubMed     Abstract available


  112. KINLOCH NN, Ritchie G, Brumme CJ, Dong W, et al
    Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results.
    J Infect Dis. 2020 Jun 28. pii: 5864227. doi: 10.1093.
    PubMed     Abstract available


  113. JACKSON ML, Scott E, Kuypers J, Nalla AK, et al
    Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16.
    J Infect Dis. 2020 Jun 19. pii: 5859587. doi: 10.1093.
    PubMed     Abstract available


  114. MINTER A, Hoschler K, Jagne YJ, Sallah H, et al
    Estimation of seasonal influenza attack rates and antibody dynamics in children using cross-sectional serological data.
    J Infect Dis. 2020 Jun 18. pii: 5859586. doi: 10.1093.
    PubMed     Abstract available


  115. ZHANG Y, Qin L, Zhao Y, Zhang P, et al
    Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
    J Infect Dis. 2020;222:34-37.
    PubMed     Abstract available


  116. ZENG QL, Yu ZJ, Gou JJ, Li GM, et al
    Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:38-43.
    PubMed     Abstract available


  117. NIE X, Fan L, Mu G, Tan Q, et al
    Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.
    J Infect Dis. 2020;222:26-33.
    PubMed     Abstract available


  118. NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
    Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:17-25.
    PubMed     Abstract available


  119. JIANG XL, Zhang XL, Zhao XN, Li CB, et al
    Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China.
    J Infect Dis. 2020;221:1948-1952.
    PubMed     Abstract available


  120. PAN Y, Yu X, Du X, Li Q, et al
    Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers.
    J Infect Dis. 2020;221:1940-1947.
    PubMed     Abstract available


  121. ALLEN J
    My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists.
    J Infect Dis. 2020;221:1938-1939.
    PubMed    


  122. URSIN RL, Liu H, Powell HR, Westerbeck J, et al
    Differential antibody recognition of H3N2 vaccine and seasonal influenza virus strains based on age, vaccine status, and sex in the 2017-18 season.
    J Infect Dis. 2020 Jun 4. pii: 5851359. doi: 10.1093.
    PubMed     Abstract available


  123. SINGH JA
    The case for why Africa should host COVID-19 candidate vaccine trials.
    J Infect Dis. 2020 Jun 3. pii: 5850913. doi: 10.1093.
    PubMed     Abstract available


  124. HOA LNM, Sullivan SG, Mai LQ, Khvorov A, et al
    Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable sero-protection: results from the Ha Nam Cohort.
    J Infect Dis. 2020 Jun 2. pii: 5850322. doi: 10.1093.
    PubMed     Abstract available


  125. KANG CK, Kim HR, Song KH, Keam B, et al
    Cell-Mediated Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
    J Infect Dis. 2020 Jun 1. pii: 5849850. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  126. ROBERTS NJ
    Further discussion of a likely explanation for decreased peripheral blood anti-influenza CD8+ T cell activity during severe infection.
    J Infect Dis. 2020 May 27. pii: 5847826. doi: 10.1093.
    PubMed    


  127. FUKUYAMA S, Iwatsuki-Horimoto K, Kiso M, Nakajima N, et al
    Pathogenesis of influenza A(H7N9) virus in aged non-human primates.
    J Infect Dis. 2020 May 20. pii: 5841298. doi: 10.1093.
    PubMed     Abstract available


  128. COWLING BJ, Thompson MG, Ng TWY, Fang VJ, et al
    Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
    J Infect Dis. 2020 May 14. pii: 5837136. doi: 10.1093.
    PubMed     Abstract available


  129. WANG F, Nie J, Wang H, Zhao Q, et al
    Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
    J Infect Dis. 2020;221:1762-1769.
    PubMed     Abstract available


  130. WANG Y, Liu Y, Liu L, Wang X, et al
    Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China.
    J Infect Dis. 2020;221:1770-1774.
    PubMed     Abstract available


  131. CUI Y, Tian M, Huang D, Wang X, et al
    A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage.
    J Infect Dis. 2020;221:1775-1781.
    PubMed     Abstract available


  132. YU P, Zhu J, Zhang Z, Han Y, et al
    A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period.
    J Infect Dis. 2020;221:1757-1761.
    PubMed     Abstract available


  133. COWLING BJ, Aiello AE
    Public Health Measures to Slow Community Spread of Coronavirus Disease 2019.
    J Infect Dis. 2020;221:1749-1751.
    PubMed    


  134. ZHANG N, Zhu L, Zhang Y, Zhou C, et al
    Circulating rather than alveolar extracellular DNA levels predict outcomes in influenza.
    J Infect Dis. 2020 May 10. pii: 5841516. doi: 10.1093.
    PubMed     Abstract available


  135. BARTSCH SM, Mitgang EA, Geller G, Cox SN, et al
    What if the Influenza Vaccine Did Not Offer Such Variable Protection?
    J Infect Dis. 2020 May 9. pii: 5835317. doi: 10.1093.
    PubMed     Abstract available


  136. TURNER JS, Lei T, Schmitz AJ, Day A, et al
    Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.
    J Infect Dis. 2020 May 5. pii: 5830762. doi: 10.1093.
    PubMed     Abstract available


  137. GRAEPEL KW, Kochhar S, Clayton EW, Edwards KE, et al
    Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 May 4. pii: 5828933. doi: 10.1093.
    PubMed    


    April 2020
  138. CIOFFI A
    COVID-19: Is Everything Appropriate to Create an Effective Vaccine?
    J Infect Dis. 2020 Apr 29. pii: 5826955. doi: 10.1093.
    PubMed    


  139. ACKERSON B, An J, Sy LS, Solano Z, et al
    Cost of Hospitalization Associated with Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults.
    J Infect Dis. 2020 Apr 17. pii: 5821154. doi: 10.1093.
    PubMed     Abstract available


  140. RYU S, Ali ST, Cowling BJ, Lau EHY, et al
    Effects of school holidays on seasonal influenza in South Korea, 2014-2016.
    J Infect Dis. 2020 Apr 11. pii: 5818974. doi: 10.1093.
    PubMed     Abstract available


  141. MOHN KG, Brokstad KA, Islam S, Oftung F, et al
    Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    J Infect Dis. 2020;221:1528-1537.
    PubMed     Abstract available


  142. INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
    Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
    J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
    PubMed     Abstract available


  143. SIEGERS JY, Novakovic B, Hulme KD, Marshall R, et al
    A high fat diet increases influenza A virus-associated cardiovascular damage.
    J Infect Dis. 2020 Apr 4. pii: 5815741. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  144. EYAL N, Lipsitch M, Smith PG
    Human challenge studies to accelerate coronavirus vaccine licensure.
    J Infect Dis. 2020 Mar 31. pii: 5814216. doi: 10.1093.
    PubMed     Abstract available


  145. SIMOES EAF, Chirikov V, Botteman M, Kwon Y, et al
    Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
    J Infect Dis. 2020;221:1256-1270.
    PubMed     Abstract available


  146. PIEDRA PA
    Long-Term Healthcare Costs Associated With Respiratory Syncytial Virus Infection in Children: The Domino Effect.
    J Infect Dis. 2020;221:1205-1207.
    PubMed    


  147. CHIRIKOV VV, Simoes EAF, Kuznik A, Kwon Y, et al
    Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;221:1244-1255.
    PubMed     Abstract available


  148. SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
    Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.
    J Infect Dis. 2020 Mar 26. pii: 5811682. doi: 10.1093.
    PubMed     Abstract available


  149. DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
    Hospital Readmissions following Laboratory-confirmed Influenza Hospitalization.
    J Infect Dis. 2020 Mar 17. pii: 5808013. doi: 10.1093.
    PubMed     Abstract available


  150. FONG MW, Leung NHL, Xiao J, Chu DKW, et al
    Presence of influenza virus on touch-surfaces in kindergartens and primary schools.
    J Infect Dis. 2020 Mar 16. pii: 5807949. doi: 10.1093.
    PubMed     Abstract available


  151. ZOU P, Wang C, Zheng S, Guo F, et al
    Invasive Pulmonary Aspergillosis in Adults With Avian Influenza A (H7N9) Pneumonia in China: A Retrospective Study.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  152. PHILIPPON DAM, Wu P, Cowling BJ, Lau EHY, et al
    Avian influenza human infections at the human-animal interface.
    J Infect Dis. 2020 Mar 10. pii: 5802683. doi: 10.1093.
    PubMed     Abstract available


  153. LEES C, Godin J, McElhaney JE, McNeil SA, et al
    Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults.
    J Infect Dis. 2020 Mar 9. pii: 5799273. doi: 10.1093.
    PubMed    


  154. GRAHAM JB, Swarts JL, Menachery VD, Gralinski LE, et al
    Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
    J Infect Dis. 2020;221:882-889.
    PubMed     Abstract available


    February 2020
  155. IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
    Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19.
    J Infect Dis. 2020 Feb 26. pii: 5758057. doi: 10.1093.
    PubMed     Abstract available


  156. SATO M, Takashita E, Katayose M, Nemoto K, et al
    Detection of variants with reduced baloxavir marboxil susceptibility after treatment of children with influenza A during the 2018/2019 influenza season.
    J Infect Dis. 2020 Feb 8. pii: 5730526. doi: 10.1093.
    PubMed     Abstract available


  157. FUENTES S, Hahn M, Chilcote K, Chemaly RF, et al
    Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
    J Infect Dis. 2020;221:636-646.
    PubMed     Abstract available


    January 2020
  158. GUBAREVA LV, Fry AM
    Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps.
    J Infect Dis. 2020;221:337-339.
    PubMed    


  159. MONTO AS
    Effectiveness of the Neuraminidase Inhibitors: The Supporting Evidence Increases.
    J Infect Dis. 2020;221:340-342.
    PubMed    


  160. BOONYARATANAKORNKIT J, Vivek M, Xie H, Pergam SA, et al
    Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation.
    J Infect Dis. 2020;221:379-388.
    PubMed     Abstract available


    December 2019
  161. DAWOOD FS, Garg S, Fink RV, Russell ML, et al
    Epidemiology and clinical outcomes of hospitalizations for acute respiratory or febrile illness and laboratory-confirmed influenza among pregnant women during six influenza seasons, 2010-2016.
    J Infect Dis. 2019 Dec 26. pii: 5687022. doi: 10.1093.
    PubMed     Abstract available


  162. SHI N, Huang J, Zhang X, Bao C, et al
    Corrigendum to: Interventions in Live Poultry Markets for the Control of Avian Influenza: A Systematic Review and Meta-analysis.
    J Infect Dis. 2019 Dec 20. pii: 5682401. doi: 10.1093.
    PubMed    


  163. KISO M, Yamayoshi S, Murakami J, Kawaoka Y, et al
    Baloxavir marboxil treatment of nude mice infected with influenza A virus.
    J Infect Dis. 2019 Dec 14. pii: 5677533. doi: 10.1093.
    PubMed     Abstract available


  164. WANG Y, Fan G, Salam A, Horby P, et al
    Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection.
    J Infect Dis. 2019 Dec 11. pii: 5673088. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  165. SCHUIT M, Gardner S, Wood S, Bower K, et al
    The Influence of Simulated Sunlight on the Inactivation of Influenza Virus in Aerosols.
    J Infect Dis. 2019 Nov 28. pii: 5645407. doi: 10.1093.
    PubMed     Abstract available


  166. TENG MN, Mejias A, Ramilo O, Peeples ME, et al
    Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
    J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
    PubMed    


  167. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.
    J Infect Dis. 2019 Nov 23. pii: 5638036. doi: 10.1093.
    PubMed     Abstract available


  168. KEITEL WA, Atmar RL
    Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
    J Infect Dis. 2019 Nov 20. pii: 5634378. doi: 10.1093.
    PubMed    


  169. WALKER JL, Zhao H, Dabrera G, Andrews N, et al
    Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015.
    J Infect Dis. 2019 Nov 9. pii: 5618766. doi: 10.1093.
    PubMed     Abstract available


  170. LEE HS, Noh JY, Shin OS, Song JY, et al
    Matrix metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection.
    J Infect Dis. 2019 Nov 6. pii: 5613981. doi: 10.1093.
    PubMed     Abstract available


  171. WALKER TA, Waite B, Thompson MG, McArthur C, et al
    Risk of Severe Influenza among Adults with Chronic Medical Conditions.
    J Infect Dis. 2019 Nov 4. pii: 5611323. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  172. COHEN C, Nunes MC
    Vaccinating Mothers to Protect Their Babies Against Influenza.
    J Infect Dis. 2019 Oct 31. pii: 5610713. doi: 10.1093.
    PubMed    


  173. FLANNERY B, Kondor RJG, Chung JR, Gaglani M, et al
    Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season.
    J Infect Dis. 2019 Oct 30. pii: 5609441. doi: 10.1093.
    PubMed     Abstract available


  174. ATMAR RL, Keitel WA
    Searching for Improved Flu Vaccines - The Time Is Now.
    J Infect Dis. 2019 Oct 30. pii: 5609442. doi: 10.1093.
    PubMed    


  175. MARTINEZ L, Cheng W, Wang X, Ling F, et al
    A Risk Classification Model to Predict Mortality Among Laboratory-Confirmed Avian Influenza A H7N9 Patients: A Population-Based Observational Cohort Study.
    J Infect Dis. 2019 Oct 17. pii: 5589175. doi: 10.1093.
    PubMed     Abstract available


  176. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged >/=65 Years.
    J Infect Dis. 2019 Oct 17. pii: 5588808. doi: 10.1093.
    PubMed    


  177. PARK YH, Chungu K, Lee SB, Woo SJ, et al
    Host-specific restriction of avian influenza virus caused by differential dynamics of ANP32 family members.
    J Infect Dis. 2019 Oct 3. pii: 5580703. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  178. L'HUILLIER AG, Ferreira VH, Hirzel C, Natori Y, et al
    Cell-Mediated Immune Responses after Influenza Vaccination of Solid Organ Transplant Recipients: a Secondary Outcomes Analysis of a Randomized Controlled Trial.
    J Infect Dis. 2019 Sep 24. pii: 5573328. doi: 10.1093.
    PubMed     Abstract available


  179. GERSHON AS, Chung H, Porter J, Campitelli MA, et al
    Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
    J Infect Dis. 2019 Sep 24. pii: 5573043. doi: 10.1093.
    PubMed     Abstract available


  180. CHESNOKOV A, Patel MC, Mishin VP, De La Cruz JA, et al
    Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir.
    J Infect Dis. 2019 Sep 21. pii: 5572441. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  181. STACEY HD, Miller MS
    Repeated Seasonal Influenza Vaccination-How Much is Too Much of a Good Thing?
    J Infect Dis. 2019 Aug 26. pii: 5554481. doi: 10.1093.
    PubMed    


  182. RICHARDS KA, Shannon I, Treanor JJ, Yang H, et al
    Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.
    J Infect Dis. 2019 Aug 26. pii: 5554480. doi: 10.1093.
    PubMed     Abstract available


  183. CHECKMAHOMED L, M'hamdi Z, Carbonneau J, Venable MC, et al
    Impact of the baloxavir-resistant polymerase acid (PA) I38T substitution on the fitness of contemporary influenza A(H1N1)pdm09 and A(H3N2) strains.
    J Infect Dis. 2019 Aug 16. pii: 5550847. doi: 10.1093.
    PubMed     Abstract available


  184. SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
    Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
    J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
    PubMed     Abstract available


  185. MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
    Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
    J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  186. SHI N, Huang J, Zhang X, Bao C, et al
    Interventions in live poultry markets for the control of avian influenza: A systematic review and meta-analysis.
    J Infect Dis. 2019 Jul 17. pii: 5533237. doi: 10.1093.
    PubMed     Abstract available


  187. VENKATESAN S, Myles PR, Bolton KJ, Muthuri SG, et al
    Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
    J Infect Dis. 2019 Jul 17. pii: 5533434. doi: 10.1093.
    PubMed     Abstract available


  188. UEHARA T, Hayden FG, Kawaguchi K, Omoto S, et al
    Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
    J Infect Dis. 2019 Jul 16. pii: 5532607. doi: 10.1093.
    PubMed     Abstract available


  189. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Effect of age on relative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries ages 65 years and older.
    J Infect Dis. 2019 Jul 9. pii: 5530548. doi: 10.1093.
    PubMed     Abstract available


  190. CHUA H, Chiu SS, Chan ELY, Feng S, et al
    Effectiveness of partial and full influenza vaccination in children aged <9 years in Hong Kong, 2011-2019.
    J Infect Dis. 2019 Jul 9. pii: 5530568. doi: 10.1093.
    PubMed     Abstract available


  191. SHORT KR, Kuiken T, van Riel D
    The role of endothelial cells in the pathogenesis of influenza in humans.
    J Infect Dis. 2019 Jul 8. pii: 5529824. doi: 10.1093.
    PubMed    


  192. JIA W, Wen X, Xie S, Dai Y, et al
    A Novel Antigenic Drift of Avian Influenza A(H7N9) Virus in Poultry, China, 2018.
    J Infect Dis. 2019 Jul 8. pii: 5529482. doi: 10.1093.
    PubMed    


  193. NG TWY, Perera RAPM, Fang VJ, Yau EM, et al
    The effect of influenza vaccination history on changes in hemagglutination inhibition titers following receipt of the 2015/16 influenza vaccine in older adults in Hong Kong.
    J Infect Dis. 2019 Jul 6. pii: 5529474. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  194. LARTEY S, Zhou F, Brokstad KA, Mohn KG, et al
    Live attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction.
    J Infect Dis. 2019 Jun 27. pii: 5524503. doi: 10.1093.
    PubMed     Abstract available


  195. GERN JE, Lee WM, Swenson CA, Nakagome K, et al
    Development of a Rhinovirus Inoculum Using a Reverse Genetics Approach.
    J Infect Dis. 2019;220:187-194.
    PubMed     Abstract available


  196. PROUD D
    Reverse Genetics and Rhinovirus-A New Approach to an Old Problem?
    J Infect Dis. 2019;220:181-183.
    PubMed    


  197. POLACK FP, Stein RT, Custovic A
    The Syndrome We Agreed to Call Bronchiolitis.
    J Infect Dis. 2019;220:184-186.
    PubMed     Abstract available


  198. ZHONG W, Levine MZ
    Stockpiled avian influenza A(H7N9) vaccines induce robust, non-neutralizing functional antibodies against antigenically drifted 5th wave A(H7N9) viruses.
    J Infect Dis. 2019 Jun 5. pii: 5511958. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  199. GREGIANINI TS, Varella IRS, Fisch P, Martins LG, et al
    Dual and Triple Infections With Influenza A and B Viruses: A Case-Control Study in Southern Brazil.
    J Infect Dis. 2019 May 29. pii: 5481580. doi: 10.1093.
    PubMed     Abstract available


  200. REDLBERGER-FRITZ M, Vietzen H, Puchhammer-Stockl E
    Association of severe influenza virus infections with CD226 (DNAM-1) variants.
    J Infect Dis. 2019 May 21. pii: 5494791. doi: 10.1093.
    PubMed     Abstract available


  201. CILLONIZ C, Dominedo C, Magdaleno D, Ferrer M, et al
    Pure viral sepsis secondary to Community-Acquired Pneumonia in adults: risk and prognostic factors.
    J Infect Dis. 2019 May 21. pii: 5494607. doi: 10.1093.
    PubMed     Abstract available


  202. MARTINEZ-BAZ I, Navascues A, Casado I, Aguinaga A, et al
    Remaining effect of influenza vaccines received in prior seasons.
    J Infect Dis. 2019 May 20. pii: 5492310. doi: 10.1093.
    PubMed     Abstract available


  203. MURRAY AF, Englund JA, Kuypers J, Tielsch JM, et al
    Infant pneumococcal carriage during influenza, RSV and hMPV respiratory illness within a maternal influenza immunization trial.
    J Infect Dis. 2019 May 6. pii: 5485855. doi: 10.1093.
    PubMed     Abstract available


  204. MANSBACH JM, Hasegawa K, Piedra PA, Avadhanula V, et al
    Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis.
    J Infect Dis. 2019;219:1804-1808.
    PubMed     Abstract available


  205. BUDD AP, Beacham L, Smith CB, Garten RJ, et al
    Birth Cohort Effects in Influenza Surveillance Data: Evidence that First Influenza Infection Affects Later Influenza-Associated Illness.
    J Infect Dis. 2019 May 3. pii: 5485579. doi: 10.1093.
    PubMed     Abstract available


  206. AMOAH S, Mishina M, Praphasiri P, Cao W, et al
    Standard dose intradermal influenza vaccine elicits similar cellular immune responses when compared to intramuscular vaccine in HIV-infected or uninfected men.
    J Infect Dis. 2019 May 2. pii: 5482500. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  207. AMBIGAPATHY G, Schmit T, Mathur RK, Nookala S, et al
    Double-Edged Role of Interleukin 17A in Streptococcus pneumoniae Pathogenesis During Influenza Virus Coinfection.
    J Infect Dis. 2019 Apr 23. pii: 5476446. doi: 10.1093.
    PubMed     Abstract available


  208. CHAN LLY, Hui KPY, Kuok DIT, Bui CHT, et al
    Risk assessment of the tropism & pathogenesis of the highly pathogenic avian influenza A/H7N9 virus using ex vivo & in vitro cultures of human respiratory tract.
    J Infect Dis. 2019 Apr 18. pii: 5475154. doi: 10.1093.
    PubMed     Abstract available


  209. GARCIA-MAURINO C, Moore-Clingenpeel M, Thomas J, Mertz S, et al
    Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2019;219:1207-1215.
    PubMed     Abstract available


  210. YU J, Peterson DR, Baran AM, Bhattacharya S, et al
    Host Gene Expression in Nose and Blood for the Diagnosis of Viral Respiratory Infection.
    J Infect Dis. 2019;219:1151-1161.
    PubMed     Abstract available


    March 2019
  211. KAMAU E, Onyango CO, Otieno GP, Kiyuka PK, et al
    An Intensive, Active Surveillance Reveals Continuous Invasion and High Diversity of Rhinovirus in Households.
    J Infect Dis. 2019;219:1049-1057.
    PubMed     Abstract available


  212. ROOT JJ
    What Are the Transmission Mechanisms of Influenza A Viruses in Wild Mammals?
    J Infect Dis. 2019 Mar 6. pii: 5369377. doi: 10.1093.
    PubMed    


  213. SOILEMETZIDOU ES, De Bruin E, Franz M, Aschenborn OHK, et al
    Diet May Drive Influenza A Virus Exposure in African Mammals.
    J Infect Dis. 2019 Mar 6. pii: 5369376. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  214. THORNTON AC, Parry-Ford F, Tessier E, Oppilamany N, et al
    Human exposures to H5N6 Avian influenza, England, 2018.
    J Infect Dis. 2019 Feb 21. pii: 5351024. doi: 10.1093.
    PubMed     Abstract available


  215. FU Y, Durrwald R, Meng F, Tong J, et al
    Infection Studies in Pigs and Porcine Airway Epithelial Cells Reveal an Evolution of A(H1N1)pdm09 Influenza A Viruses Toward Lower Virulence.
    J Infect Dis. 2019 Feb 18. pii: 5334094. doi: 10.1093.
    PubMed     Abstract available


  216. VAN ERP EA, Feyaerts D, Duijst M, Mulder HL, et al
    Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function.
    J Infect Dis. 2019;219:723-733.
    PubMed     Abstract available


  217. ZELNER J, Petrie JG, Trangucci R, Martin ET, et al
    Effects of sequential influenza A(H1N1)pdm09 vaccination on antibody waning.
    J Infect Dis. 2019 Feb 4. pii: 5306487. doi: 10.1093.
    PubMed     Abstract available


  218. LEVINE MZ, Martin ET, Petrie JG, Lauring AS, et al
    Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season.
    J Infect Dis. 2019 Feb 4. pii: 5306481. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  219. PAULES CI, Fauci AS
    Influenza Vaccines: Good, But We Can Do Better.
    J Infect Dis. 2019 Jan 31. pii: 5304932. doi: 10.1093.
    PubMed    


  220. SAAD-ROY CM, McDermott AB, Grenfell BT
    Dynamic perspectives on the search for a universal influenza vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304934. doi: 10.1093.
    PubMed     Abstract available


  221. CRANK MC, Mascola JR, Graham BS
    Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304928. doi: 10.1093.
    PubMed    


  222. RUDRARAJU R, Mordant F, Subbarao K
    How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304927. doi: 10.1093.
    PubMed    


  223. ROSS TM
    Universal Influenza Vaccine Approaches Employing Full-Length or Head-only HA Proteins.
    J Infect Dis. 2019 Jan 31. pii: 5304925. doi: 10.1093.
    PubMed     Abstract available


  224. SANT AJ
    The way forward: Potentiating protective immunity to novel and pandemic influenza through engagement of memory CD4 T cells.
    J Infect Dis. 2019 Jan 31. pii: 5304931. doi: 10.1093.
    PubMed     Abstract available


  225. CROWE JE JR
    Antibody Determinants of Influenza Immunity.
    J Infect Dis. 2019 Jan 31. pii: 5304924. doi: 10.1093.
    PubMed     Abstract available


  226. NEUMANN G, Kawaoka Y
    Can We Predict The Next Influenza Pandemics?
    J Infect Dis. 2019 Jan 31. pii: 5304929. doi: 10.1093.
    PubMed     Abstract available


  227. SAELENS X
    The Role of M2e in the Development of Universal Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304896. doi: 10.1093.
    PubMed     Abstract available


  228. EICHELBERGER MC, Monto AS
    Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection.
    J Infect Dis. 2019 Jan 31. pii: 5304892. doi: 10.1093.
    PubMed     Abstract available


  229. KRAMMER F, Palese P
    Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain.
    J Infect Dis. 2019 Jan 31. pii: 5304926. doi: 10.1093.
    PubMed     Abstract available


  230. MORENS DM, Taubenberger JK
    Making Universal Influenza Vaccines: Lessons from the 1918 Pandemic.
    J Infect Dis. 2019 Jan 31. pii: 5304851. doi: 10.1093.
    PubMed    


  231. ORTIZ JR, Neuzil KM
    Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304930. doi: 10.1093.
    PubMed     Abstract available


  232. KANEKIYO M, Ellis D, King NP
    New Vaccine Design and Delivery Technologies.
    J Infect Dis. 2019 Jan 31. pii: 5304933. doi: 10.1093.
    PubMed     Abstract available


  233. ANDERSON LJ, Peret TC, Piedra PA
    RSV Strains and Disease Severity.
    J Infect Dis. 2019;219:514-516.
    PubMed    


  234. MIDULLA F, Nenna R, Scagnolari C, Petrarca L, et al
    How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis.
    J Infect Dis. 2019;219:526-534.
    PubMed     Abstract available


  235. PRASAD N, Huang QS, Wood T, Aminisani N, et al
    Influenza associated outcomes among pregnant, post-partum, and non-pregnant women of reproductive age.
    J Infect Dis. 2019 Jan 23. pii: 5299596. doi: 10.1093.
    PubMed     Abstract available


  236. CABALLERO MT, Bianchi AM, Nuno A, Ferretti AJP, et al
    Mortality Associated With Acute Respiratory Infections Among Children at Home.
    J Infect Dis. 2019;219:358-364.
    PubMed     Abstract available


  237. FURUSE Y, Tamaki R, Okamoto M, Saito-Obata M, et al
    Association Between Preceding Viral Respiratory Infection and Subsequent Respiratory Illnesses Among Children: A Prospective Cohort Study in the Philippines.
    J Infect Dis. 2019;219:197-205.
    PubMed     Abstract available


  238. MAZUR NI, Horsley NM, Englund JA, Nederend M, et al
    Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
    J Infect Dis. 2019;219:59-67.
    PubMed     Abstract available


    December 2018
  239. HELLFERSCEE O, Treurnicht FK, Walaza S, du Plessis M, et al
    The fraction of rhinovirus detections attributable to mild and severe respiratory illness in a high HIV-prevalence setting, South Africa, 2013-2015.
    J Infect Dis. 2018 Dec 22. pii: 5257995. doi: 10.1093.
    PubMed     Abstract available


  240. LAUZON-JOSET JF, Scott NM, Mincham KT, Stumbles PA, et al
    Pregnancy induces a steady-state shift in alveolar macrophage M1/M2 phenotype that is associated with a heightened severity of Influenza infection: mechanistic insight using mouse models.
    J Infect Dis. 2018 Dec 21. pii: 5257349. doi: 10.1093.
    PubMed     Abstract available


  241. HOWARD LM, Goll JB, Jensen TL, Hoek KL, et al
    AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures In Human Peripheral Blood Mononuclear Cells.
    J Infect Dis. 2018 Dec 19. pii: 5253567. doi: 10.1093.
    PubMed     Abstract available


  242. FLANNERY B, Fry AM
    Comparing influenza vaccine types: the path towards improved influenza vaccine strategies.
    J Infect Dis. 2018 Dec 18. pii: 5250956. doi: 10.1093.
    PubMed    


  243. IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
    Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017-18.
    J Infect Dis. 2018 Dec 18. pii: 5250955. doi: 10.1093.
    PubMed     Abstract available


  244. NG TWY, Cowling BJ, Gao HZ, Thompson MG, et al
    Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis.
    J Infect Dis. 2018 Dec 14. pii: 5247419. doi: 10.1093.
    PubMed     Abstract available


  245. KEITEL WA, Atmar RL
    Influenza Vaccines after Seven Decades: Still on the Learning Curve.
    J Infect Dis. 2018 Dec 14. pii: 5248489. doi: 10.1093.
    PubMed    


  246. FERDINANDS JM, Gaglani M, Martin ET, Middleton D, et al
    Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    J Infect Dis. 2018 Dec 14. pii: 5248488. doi: 10.1093.
    PubMed     Abstract available


  247. COHEN C, Tshangela A, Valley-Omar Z, Iyengar P, et al
    Household transmission of seasonal influenza from HIV-infected and -uninfected individuals in South Africa, 2013-2014.
    J Infect Dis. 2018 Dec 12. pii: 5240968. doi: 10.1093.
    PubMed     Abstract available


  248. ZOST SJ, Wu NC, Hensley SE, Wilson IA, et al
    Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens.
    J Infect Dis. 2018 Dec 9. pii: 5236836. doi: 10.1093.
    PubMed    


  249. JENNIFER R, Green WD, Alwarawrah Y, Nichols AG, et al
    Obesity-induced changes in T cell metabolism are associated with impaired memory T cell response to influenza and are not reversed with weight loss.
    J Infect Dis. 2018 Dec 9. pii: 5236852. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  250. SANYAL M, Holmes TH, Maecker H, Albrecht RA, et al
    Diminished B-cell response after repeat influenza vaccination.
    J Infect Dis. 2018 Nov 28. pii: 5212478. doi: 10.1093.
    PubMed     Abstract available


  251. LEE N, Ison MG
    Inhibiting Viral Polymerase and Neuraminidase in Treating Influenza.
    J Infect Dis. 2018 Nov 14. pii: 5183287. doi: 10.1093.
    PubMed    


  252. FINBERG RW, Lanno R, Anderson D, Fleischhackl R, et al
    Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
    J Infect Dis. 2018 Nov 14. pii: 5183286. doi: 10.1093.
    PubMed     Abstract available


  253. POIROT E, Levine MZ, Russell K, Stewart RJ, et al
    Detection of Avian Influenza A(H7N2) Virus Infection Among Animal Shelter Workers Using a Novel Serological Approach-New York City, 2016-2017.
    J Infect Dis. 2018 Nov 5. pii: 5161222. doi: 10.1093.
    PubMed     Abstract available


  254. JAIN S, Murray EL
    The Cat's Meow: Using Novel Serological Approaches to Identify Cat-to-Human Influenza A(H7N2) Transmission.
    J Infect Dis. 2018 Nov 3. pii: 5159540. doi: 10.1093.
    PubMed    


    September 2018
  255. SCHELLER N, Herold S, Kellner R, Bertrams W, et al
    Pro-viral miRNAs detected in BALF extracellular vesicles of patients with influenza virus-induced ARDS.
    J Infect Dis. 2018 Sep 15. pii: 5098403. doi: 10.1093.
    PubMed     Abstract available


  256. L'HUILLIER AG, Ferreira VH, Hirzel C, Cordero E, et al
    Cytokine Profiles and Severity of Influenza Infection in Transplant Recipients.
    J Infect Dis. 2018 Sep 5. pii: 5091250. doi: 10.1093.
    PubMed     Abstract available


  257. MORI I
    1918 H1N1 Influenza Virus Infection-Induced Proinflammatory Cytokines in the Olfactory Bulb Could Trigger Lethargic Disease.
    J Infect Dis. 2018 Sep 4. pii: 5090304. doi: 10.1093.
    PubMed    


    August 2018
  258. MAIER HE, Lopez R, Sanchez N, Ng S, et al
    Obesity Increases the Duration of Influenza A Virus Shedding in Adults.
    J Infect Dis. 2018 Aug 2. pii: 5051913. doi: 10.1093.
    PubMed     Abstract available


  259. LOY H, Kuok DIT, Hui KPY, Choi MHL, et al
    Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A/H5N1-associated acute lung injury.
    J Infect Dis. 2018 Aug 2. pii: 5064213. doi: 10.1093.
    PubMed     Abstract available


  260. SCHULTZ-CHERRY S
    Beyond Disease Severity: The Impact of Obesity on Influenza A Virus Shedding.
    J Infect Dis. 2018 Aug 2. pii: 5051914. doi: 10.1093.
    PubMed    


    July 2018
  261. YOGARATNAM J, Rito J, Kakuda TN, Fennema H, et al
    Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study.
    J Infect Dis. 2018 Jul 26. pii: 5060129. doi: 10.1093.
    PubMed     Abstract available


  262. TREANOR J
    Influenza Challenge and the Challenge of Drug Development.
    J Infect Dis. 2018 Jul 26. pii: 5060130. doi: 10.1093.
    PubMed    


  263. HUANG QS, Bandaranayake D, Wood T, Newbern EC, et al
    Risk factors and attack rates of seasonal influenza infection: results of the SHIVERS seroepidemiologic cohort study.
    J Infect Dis. 2018 Jul 17. pii: 5054657. doi: 10.1093.
    PubMed     Abstract available


  264. COWLING BJ, Sullivan SG
    The value of neuraminidase inhibition antibody titers in influenza seroepidemiology.
    J Infect Dis. 2018 Jul 14. pii: 5053899. doi: 10.1093.
    PubMed    


  265. ZHOU X, Wang Y, Liu H, Guo F, et al
    Effectiveness of market-level biosecurity at reducing exposure of poultry and humans to avian influenza: a systematic review and meta-analysis.
    J Infect Dis. 2018 Jul 7. pii: 5050226. doi: 10.1093.
    PubMed     Abstract available


  266. PETRIE JG, Lauring AS
    Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
    J Infect Dis. 2018 Jul 5. pii: 5049176. doi: 10.1093.
    PubMed    


  267. NING T, Nie J, Huang W, Li C, et al
    Antigenic Drift of H7N9 Viral Hemagglutinin.
    J Infect Dis. 2018 Jul 5. pii: 5049177. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  268. LIU F, Tzeng WP, Horner L, Kamal RP, et al
    Both Immune Priming and Egg-adaptation in the Vaccine Influence Antibody Responses to Circulating A(H1N1)pdm09 Viruses Following Influenza Vaccination in Adults.
    J Infect Dis. 2018 Jun 21. pii: 5042019. doi: 10.1093.
    PubMed     Abstract available


  269. KORMUTH KA, Lin K, Prussin AJ 2nd, Vejerano EP, et al
    Influenza Virus Infectivity Is Retained in Aerosols and Droplets Independent of Relative Humidity.
    J Infect Dis. 2018 Jun 7. pii: 5025997. doi: 10.1093.
    PubMed     Abstract available


  270. HOULIHAN C, Frampton D, Ferns RB, Raffle J, et al
    The use of whole genome sequencing in the investigation of a nosocomial influenza virus outbreak.
    J Infect Dis. 2018 Jun 5. pii: 5033093. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  271. VANDERVEN HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, et al
    Anti-influenza Hyperimmune Immunoglobulin Enhances Fc-functional Antibody Immunity during Human Influenza Infection.
    J Infect Dis. 2018 May 31. pii: 5026129. doi: 10.1093.
    PubMed     Abstract available


  272. GUAN W, Wu NC, Lee HHY, Li Y, et al
    Clinical Correlations of Transcriptional Profile in Patients Infected with Avian Influenza H7N9 Virus.
    J Infect Dis. 2018 May 28. pii: 5017262. doi: 10.1093.
    PubMed     Abstract available


  273. VON MOLLENDORF C, Hellferscee O, Valley-Omar Z, Treurnicht FK, et al
    Influenza viral shedding in a prospective cohort of HIV-infected and -uninfected children and adults in 2 provinces of South Africa, 2012-2014.
    J Infect Dis. 2018 May 24. pii: 5002738. doi: 10.1093.
    PubMed     Abstract available


  274. RICHARDS KA, Treanor JJ, Nayak JL, Sant AJ, et al
    Overarching Immunodominance Patterns and Substantial Diversity in Specificity and Functionality in the Circulating Human Influenza A and B CD4 T Cell Repertoire.
    J Infect Dis. 2018 May 12. pii: 4995466. doi: 10.1093.
    PubMed     Abstract available


  275. CHAN KF, Carolan LA, Korenkov D, Druce J, et al
    Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.
    J Infect Dis. 2018 May 8. pii: 4994087. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  276. CARROLL TD, Jegaskanda S, Matzinger SR, Fritts L, et al
    A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge.
    J Infect Dis. 2018 Apr 26. pii: 4986227. doi: 10.1093.
    PubMed     Abstract available


  277. DE VRIES RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, et al
    Induction of Cross-Clade Antibody and T-Cell Responses by an MVA-Based Influenza H5N1 Vaccine in a Randomized Phase I/IIa Clinical Trial.
    J Infect Dis. 2018 Apr 18. pii: 4975691. doi: 10.1093.
    PubMed     Abstract available


  278. BORGOGNA TR, Hisey B, Heitmann E, Obar JJ, et al
    Secondary Bacterial Pneumonia by Staphylococcus aureus following Influenza A Infection Is SaeR/S Dependent.
    J Infect Dis. 2018 Apr 13. pii: 4970008. doi: 10.1093.
    PubMed     Abstract available


  279. VAN DE SANDT CE, Sagong KA, Pronk MR, Bestebroer TM, et al
    H1N1pdm09 Influenza Virus and its Descendants Lack Extra-Epitopic Amino Acid Residues Associated with Reduced Recognition by M158-66-specific CD8+ T-cells.
    J Infect Dis. 2018 Apr 12. pii: 4969428. doi: 10.1093.
    PubMed     Abstract available


  280. WANG Y, Guo Q, Yan Z, Zhou D, et al
    Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection.
    J Infect Dis. 2018 Apr 10. pii: 4965883. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  281. LANGLEY JM, MacDonald LD, Weir GM, MacKinnon-Cameron D, et al
    A Respiratory Syncytial Virus vaccine based on the Small Hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study.
    J Infect Dis. 2018 Mar 30. pii: 4956800. doi: 10.1093.
    PubMed     Abstract available


  282. POLACK FP
    Crafting Live-Attenuated Vaccines Against Respiratory Syncytial Virus.
    J Infect Dis. 2018 Mar 2. pii: 4917537. doi: 10.1093.
    PubMed    


  283. BUCHHOLZ UJ, Cunningham CK, Muresan P, Gnanashanmugam D, et al
    Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    J Infect Dis. 2018 Mar 2. pii: 4917539. doi: 10.1093.
    PubMed     Abstract available


  284. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.
    J Infect Dis. 2018 Mar 2. pii: 4917538. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  285. ERBELDING EJ, Post D, Stemmy E, Roberts PC, et al
    A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
    J Infect Dis. 2018 Feb 28. pii: 4904047. doi: 10.1093.
    PubMed     Abstract available


  286. YOUNG-XU Y, Van Aalst R, Mahmud SM, Rothman KJ, et al
    Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients.
    J Infect Dis. 2018 Feb 14. pii: 4858294. doi: 10.1093.
    PubMed     Abstract available


  287. XIANG D, Shen X, Pu Z, Irwin DM, et al
    Convergent Evolution of Human-Isolated H7N9 Avian Influenza A Viruses.
    J Infect Dis. 2018 Feb 9. pii: 4846861. doi: 10.1093.
    PubMed     Abstract available


  288. BERAN J, Lickliter JD, Schwarz TF, Johnson C, et al
    Safety and immunogenicity of 3 formulations of an investigational respiratory syncytial virus vaccine in non-pregnant women: results from two phase II trials.
    J Infect Dis. 2018 Feb 1. pii: 4833521. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  289. MAEMURA T, Fukuyama S, Sugita Y, Lopes TJS, et al
    Lung-derived exosomal miR-483-3p regulates the innate immune response to influenza virus infection.
    J Infect Dis. 2018 Jan 24. pii: 4823229. doi: 10.1093.
    PubMed     Abstract available


  290. CHENG AC, Subbarao K
    Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle.
    J Infect Dis. 2018 Jan 18. pii: 4816917. doi: 10.1093.
    PubMed    


  291. FLANNERY B, Smith C, Garten RJ, Levine MZ, et al
    Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
    J Infect Dis. 2018 Jan 18. pii: 4816916. doi: 10.1093.
    PubMed     Abstract available


  292. ZHU L, Liu L, Zhang Y, Pu L, et al
    High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection.
    J Infect Dis. 2018;217:428-437.
    PubMed     Abstract available


  293. STORCH GA
    Respiratory Viruses in Babies: Important Insights From Down Under.
    J Infect Dis. 2018;217:350-352.
    PubMed    


  294. CHIU SS, Kwan MYW, Feng S, Wong JSC, et al
    Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/17.
    J Infect Dis. 2018 Jan 16. pii: 4810661. doi: 10.1093.
    PubMed     Abstract available


  295. ROLFES MA, Gross FL, Flannery B, Meyers AFA, et al
    Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011.
    J Infect Dis. 2018 Jan 12. pii: 4803439. doi: 10.1093.
    PubMed     Abstract available


  296. DE WIT E, Siegers J, Cronin JM, Weatherman S, et al
    1918 H1N1 influenza virus replicates and induces pro-inflammatory cytokine responses in extra-respiratory tissues of ferrets.
    J Infect Dis. 2018 Jan 10. pii: 4796831. doi: 10.1093.
    PubMed     Abstract available


  297. LAURIE KL, Horman W, Carolan LA, Chan KF, et al
    Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.
    J Infect Dis. 2018 Jan 6. pii: 4792826. doi: 10.1093.
    PubMed     Abstract available


  298. GOLDSTEIN E, Nguyen HH, Liu P, Viboud C, et al
    On the Relative Role of Different Age Groups During Epidemics Associated With Respiratory Syncytial Virus.
    J Infect Dis. 2018;217:238-244.
    PubMed     Abstract available


    December 2017
  299. RAMILO O, Rodriguez-Fernandez R, Mejias A
    One Step Forward in the Road Toward a Universal Influenza Vaccine.
    J Infect Dis. 2017;217:1-2.
    PubMed    


  300. DE VRIES RD, Nieuwkoop NJ, van der Klis FRM, Koopmans MPG, et al
    Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.
    J Infect Dis. 2017;217:3-11.
    PubMed     Abstract available


  301. CAPELLA C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, et al
    Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
    J Infect Dis. 2017;216:1398-1406.
    PubMed     Abstract available


  302. MADARAS-KELLY K, Remington R, Hruza H, Xu D, et al
    The Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Post-Influenza Deaths.
    J Infect Dis. 2017 Dec 9. pii: 4718125. doi: 10.1093.
    PubMed    


  303. YOUNG B, Sadarangani S, Jiang L, Wilder-Smith A, et al
    The Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis and Meta-regression of Test-Negative Design Case-control Studies.
    J Infect Dis. 2017 Dec 6. pii: 4694421. doi: 10.1093.
    PubMed     Abstract available


  304. OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
    Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study.
    J Infect Dis. 2017 Dec 5. pii: 4693945. doi: 10.1093.
    PubMed     Abstract available


  305. LIU WC, Lin CS, Yeh CC, Wu HY, et al
    Effect of Influenza Vaccination Against Postoperative Pneumonia and Mortality for Geriatric Patients Receiving Major Surgery: A Nationwide Matched Study.
    J Infect Dis. 2017 Dec 5. pii: 4690590. doi: 10.1093.
    PubMed     Abstract available


  306. WAGHMARE A, Xie H, Kimball L, Yi J, et al
    Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
    J Infect Dis. 2017;216:1235-1244.
    PubMed     Abstract available


    November 2017
  307. MAKVANDI-NEJAD S, Laurenson-Schafer H, Wang L, Wellington D, et al
    Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    J Infect Dis. 2017 Nov 30. pii: 4676001. doi: 10.1093.
    PubMed     Abstract available


  308. LU X, Schneider E, Jain S, Bramley AM, et al
    Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia.
    J Infect Dis. 2017;216:1104-1111.
    PubMed     Abstract available


  309. KISO M, Lopes TJS, Yamayoshi S, Ito M, et al
    Combination Therapy with Neuraminidase and Polymerase Inhibitors in Nude Mice Infected with Influenza Virus.
    J Infect Dis. 2017 Nov 25. pii: 4662841. doi: 10.1093.
    PubMed     Abstract available


  310. MARIANI TJ, Qiu X, Chu C, Wang L, et al
    Association of Dynamic Changes in the CD4 T-Cell Transcriptome With Disease Severity During Primary Respiratory Syncytial Virus Infection in Young Infants.
    J Infect Dis. 2017;216:1027-1037.
    PubMed     Abstract available


  311. SEON SH, Choi JA, Yang E, Pyo S, et al
    Intranasal Immunization with an Attenuated Pep27 Mutant Provides Protection from Influenza Virus and Secondary Pneumococcal Infections.
    J Infect Dis. 2017 Nov 14. doi: 10.1093.
    PubMed     Abstract available


  312. WONG SS, Oshansky CM, Guo XJ, Ralston J, et al
    Severe influenza is characterized by prolonged immune activation: results from the SHIVERS cohort study.
    J Infect Dis. 2017 Nov 3. doi: 10.1093.
    PubMed     Abstract available


  313. VANDERVEN HA, Jegaskanda S, Wines BD, Hogarth PM, et al
    Antibody-dependent cellular cytotoxicity (ADCC) responses to seasonal influenza vaccination in older adults.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    PubMed     Abstract available


    October 2017
  314. SKOWRONSKI DM, Chambers C, De Serres G
    Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed    


  315. SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al
    Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada.
    J Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Abstract available


    September 2017
  316. BELONGIA E
    Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Sep 27. doi: 10.1093.
    PubMed    


  317. OXMAN MN, Harbecke R, Koelle DM
    Clinical Usage of the Candidate Adjuvanted HZ/su Zoster Vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed    


  318. SCHWARZ TF, Aggarwal N, Moeckesch B, Schenkenberger I, et al
    Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


  319. FALLOON J, Yu J, Esser MT, Villafana T, et al
    An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Abstract available


  320. LANGLEY JM
    Vaccine Prevention of Respiratory Syncytial Virus in Older Adults: The Work Continues.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed    


  321. WIDDOWSON MA, Bresee JS, Jernigan DB
    The Global Threat of Animal Influenza Viruses of Zoonotic Concern: Then and Now.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  322. LIU B, Havers FP, Zhou L, Zhong H, et al
    Clusters of Human Infections With Avian Influenza A(H7N9) Virus in China, March 2013 to June 2015.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  323. LIU F, Veguilla V, Gross FL, Gillis E, et al
    Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  324. HAVERS FP, Campbell AP, Uyeki TM, Fry AM, et al
    Commentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  325. CHAKRABORTY A, Rahman M, Hossain MJ, Khan SU, et al
    Mild Respiratory Illness Among Young Children Caused by Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in Dhaka, Bangladesh, 2011.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  326. VENTER M, Treurnicht FK, Buys A, Tempia S, et al
    Risk of Human Infections With Highly Pathogenic H5N2 and Low Pathogenic H7N1 Avian Influenza Strains During Outbreaks in Ostriches in South Africa.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  327. CREANGA A, Hang NLK, Cuong VD, Nguyen HT, et al
    Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal-Human Interface in Vietnam, 2003-2010.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  328. LEVINE MZ, Holiday C, Liu F, Jefferson S, et al
    Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  329. GUBAREVA LV, Sleeman K, Guo Z, Yang H, et al
    Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  330. PULIT-PENALOZA JA, Simpson N, Yang H, Creager HM, et al
    Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  331. JONES EN, Amoah S, Cao W, Sambhara S, et al
    An Adjuvanted A(H5N1) Subvirion Vaccine Elicits Virus-Specific Antibody Response and Improves Protection Against Lethal Influenza Viral Challenge in Mouse Model of Protein Energy Malnutrition.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  332. BELSER JA, Creager HM, Zeng H, Maines TR, et al
    Pathogenesis, Transmissibility, and Tropism of a Highly Pathogenic Avian Influenza A(H7N7) Virus Associated With Human Conjunctivitis in Italy, 2013.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  333. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.
    J Infect Dis. 2017;216:697-702.
    PubMed     Abstract available


  334. SCHLABERG R, Ampofo K, Tardif KD, Stockmann C, et al
    Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia.
    J Infect Dis. 2017;216:688-696.
    PubMed     Abstract available


  335. DUNKLE LM, Izikson R, Patriarca PA, Goldenthal KL, et al
    Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Abstract available


  336. KISO M, Iwatsuki-Horimoto K, Yamayoshi S, Uraki R, et al
    Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.
    J Infect Dis. 2017;216:582-593.
    PubMed     Abstract available


    August 2017
  337. NEUZIL KM, Chen WH
    Influenza Vaccines for Older Persons: Progress and Pitfalls.
    J Infect Dis. 2017;216:397-398.
    PubMed    


  338. ANDREW MK, Shinde V, Ye L, Hatchette T, et al
    The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
    J Infect Dis. 2017;216:405-414.
    PubMed     Abstract available


  339. VAN BEEK J, Veenhoven RH, Bruin JP, van Boxtel RAJ, et al
    Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.
    J Infect Dis. 2017;216:415-424.
    PubMed     Abstract available


  340. MCELHANEY JE, McNeil SA
    Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults.
    J Infect Dis. 2017;216:399-401.
    PubMed    


  341. MIDGLEY CM, Haynes AK, Baumgardner JL, Chommanard C, et al
    Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing.
    J Infect Dis. 2017;216:345-355.
    PubMed     Abstract available


    July 2017
  342. YOON SW, Wong SS, Zhu H, Chen R, et al
    Dysregulated T-Helper Type 1 (Th1):Th2 Cytokine Profile and Poor Immune Response in Pregnant Ferrets Infected With 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017 Jul 18. doi: 10.1093.
    PubMed     Abstract available


  343. MOE N, Stenseng IH, Krokstad S, Christensen A, et al
    The Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Hospitalized Norwegian Children.
    J Infect Dis. 2017;216:110-116.
    PubMed     Abstract available


    June 2017
  344. PAULES CI, Lakdawala S, McAuliffe JM, Paskel M, et al
    An HA stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    PubMed     Abstract available


  345. SHORT KR, Veeris R, Leijten LM, van den Brand JM, et al
    Proinflammatory Cytokine Responses in Extra-Respiratory Tissues During Severe Influenza.
    J Infect Dis. 2017 Jun 16. doi: 10.1093.
    PubMed     Abstract available


  346. MONTO AS, Malosh RE, Petrie JG, Martin ET, et al
    The Doctrine of Original Antigenic Sin: Separating Good From Evil.
    J Infect Dis. 2017;215:1782-1788.
    PubMed     Abstract available


  347. CHUNG JR, Flannery B, Zimmerman RK, Nowalk MP, et al
    Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S.
    J Infect Dis. 2017 Jun 13. doi: 10.1093.
    PubMed    


  348. DATTA S, Walsh EE, Peterson DR, Falsey AR, et al
    Can Analysis of Routine Viral Testing Provide Accurate Estimates of Respiratory Syncytial Virus Disease Burden in Adults?
    J Infect Dis. 2017;215:1706-1710.
    PubMed     Abstract available


    May 2017
  349. RANDOLPH AG, Yip WK, Allen EK, Rosenberger CM, et al
    Evaluation of IFITM3 rs12252 Association with Severe Pediatric Influenza Infection.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Abstract available


  350. LEE N, Cao B, Ke C, Lu H, et al
    IFITM3, TLR3, and CD55 Genes SNPs and Cumulative Ge-netic Risks for Severe Outcomes in Chinese Patients with H7N9 / H1N1pdm09 Influenza.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Abstract available


  351. HIROSE R, Nakaya T, Naito Y, Daidoji T, et al
    Mechanism of human influenza virus RNA persistence and virion survival in feces: mucus protects virions from acid and digestive juices.
    J Infect Dis. 2017 May 11. doi: 10.1093.
    PubMed     Abstract available


  352. AGUAYO-HIRALDO PI, Arasaratnam RJ, Tzannou I, Kuvalekar M, et al
    Characterizing the cellular immune response to Parainfluenza virus 3.
    J Infect Dis. 2017 May 2. doi: 10.1093.
    PubMed     Abstract available


  353. WAGHMARE A, Englund JA, Boeckh M
    Parainfluenza Virus 3-specific T Cells: Opportunity for Intervention?
    J Infect Dis. 2017 May 2. doi: 10.1093.
    PubMed    


  354. SCHLABERG R, Queen K, Simmon K, Tardif K, et al
    Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology.
    J Infect Dis. 2017;215:1407-1415.
    PubMed     Abstract available


    April 2017
  355. THWAITES RS, Ito K, Chingono JMS, Coates M, et al
    Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis.
    J Infect Dis. 2017;215:1240-1244.
    PubMed     Abstract available


  356. HUANG X, Mengersen K, Milinovich G, Hu W, et al
    Effect of weather variability on seasonal influenza among different age groups in Queensland, Australia: A Bayesian spatiotemporal analysis.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  357. MOHN KG, Zhou F, Brokstad KA, Sridhar S, et al
    Live attenuated influenza vaccination boosts durable cross-reactive and protection-associated T-cells in children.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  358. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017;215:841-843.
    PubMed    


  359. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017;215:847-855.
    PubMed     Abstract available


  360. SHAY DK, Chillarige Y, Kelman J, Forshee RA, et al
    Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Abstract available


  361. MONTO AS
    Moving Toward Improved Influenza Vaccines.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed    


  362. CASERTA MT, Qiu X, Tesini B, Wang L, et al
    Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants.
    J Infect Dis. 2017;215:750-756.
    PubMed     Abstract available


    February 2017
  363. LIU L, Nachbagauer R, Zhu L, Huang Y, et al
    Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    J Infect Dis. 2017;215:518-528.
    PubMed     Abstract available


  364. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed    


  365. BOECKH M, Stevens-Ayers T, Travi G, Huang ML, et al
    Bronchoalveolar Lavage DNA Quantification in Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed    


  366. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed    


  367. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed    


    January 2017
  368. ARNOTT A, Carville K, Franklin L, Sullivan SG, et al
    Consecutive Influenza Infections in Both Adults and Children.
    J Infect Dis. 2017 Jan 18. doi: 10.1093.
    PubMed    


  369. HEIKKINEN T, Ojala E, Waris M
    Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children.
    J Infect Dis. 2017;215:17-23.
    PubMed     Abstract available


    December 2016
  370. EWING A, Lee EC, Viboud C, Bansal S, et al
    Contact, travel, and transmission: The impact of winter holidays on influenza dynamics in the United States.
    J Infect Dis. 2016 Dec 28. pii: jiw642. doi: 10.1093.
    PubMed     Abstract available


  371. HADLER JL
    Christmas-New Year influenza lull: not too late for vaccination.
    J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
    PubMed    


  372. JEGASKANDA S, Co MD, Cruz J, Subbarao K, et al
    Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein.
    J Infect Dis. 2016 Dec 23. pii: jiw629. doi: 10.1093.
    PubMed     Abstract available


  373. TRIEU MC, Zhou F, Lartey S, Jul-Larsen A, et al
    Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.
    J Infect Dis. 2016 Dec 22. pii: jiw619. doi: 10.1093.
    PubMed     Abstract available


  374. PETRIE JG, Parkhouse K, Ohmit SE, Malosh RE, et al
    Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    J Infect Dis. 2016;214:1947-1951.
    PubMed     Abstract available


  375. SHIMIZU K, Wulandari L, Poetranto ED, Setyoningrum RA, et al
    Seroevidence for a High Prevalence of Subclinical Infection With Avian Influenza A(H5N1) Virus Among Workers in a Live-Poultry Market in Indonesia.
    J Infect Dis. 2016;214:1929-1936.
    PubMed     Abstract available


  376. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016.
    PubMed    


  377. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016 Dec 7. doi: 10.1093.
    PubMed    


    October 2016
  378. LIU WJ, Tan S, Zhao M, Quan C, et al
    Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions.
    J Infect Dis. 2016.
    PubMed     Abstract available


  379. MORI I
    Vaccination Effectively Prevents Central Nervous System Invasion by Influenza A(H5N1) Virus Through the Olfactory Pathway: A Proposed Mechanism of Neuroprotection.
    J Infect Dis. 2016.
    PubMed    



  380. Live attenuated influenza vaccine in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed    


    September 2016
  381. LANGLEY JM, Aggarwal N, Toma A, Halperin SA, et al
    A randomized, controlled, observer-blind Phase I study of the safety and immunogenicity of a Respiratory Syncytial Virus vaccine with or without alum adjuvant.
    J Infect Dis. 2016.
    PubMed     Abstract available


  382. LE GARS M, Kay AW, Bayless NL, Aziz N, et al
    Increased Pro-Inflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.
    J Infect Dis. 2016.
    PubMed     Abstract available


  383. YU KO, Randolph AG, Agan AA, Yip WK, et al
    Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
    J Infect Dis. 2016.
    PubMed     Abstract available


  384. MADAN A, Segall N, Ferguson M, Frenette L, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults.
    J Infect Dis. 2016.
    PubMed     Abstract available


    July 2016
  385. HOFT DF, Lottenbach K, Goll JB, Hill H, et al
    Priming Vaccination with H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.
    J Infect Dis. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: